These evidences could reflect that the efficacy of PZH inhibits the regulation of colorectal cancer on HLECs to alleviate tumor lymphangiogenesis and metastasis by downregulating ANRIL dependent PI3K/AKT/VEGF-C pathway. The gene discussed is CDKN2B-AS1; the disease is colorectal cancer.